We do look foolish sitting at a $6.5m market cap. The story is no doubt bias, but not outlandish.
What say you Brian? Are we still on track? If that story isn't a catalyst what will we need to start the fire? Low volume here is worrisome.
Sentiment: Strong Buy
Yes, we are still on track. We're almost there...that's all I can say.
there are 2 patents mrna has that are worth a lot. bankrupt is the best path if you keep these 2 patents. we may get f d but someone will make millions. not me as a long.
Was there a story today? Did anyone read the story on Genomeweb?
what reuters story